Results 31 to 40 of about 213,511 (352)
Multidisciplinary Approach to a Patient with Acinar Cell Carcinoma, a Rare Pancreatic Malignancy
healthbook TIMES. Oncology Hematology, 2021 Acinar cell carcinoma (ACC) of the pancreas is a relatively rare malignant neoplasm that constitutes about 1% of all pancreatic exocrine tumors. The disease is generally managed similarly as pancreatic ductal adenocarcinoma (PDAC), with surgical ...
Maria Celeste Palmarocchi +3 more
doaj +2 more sources
Oncology Letters, 2017 Pancreatic cancer is classified as ductal, acinar, neuroendocrine carcinoma or pancreatoblastoma. Ductal and acinar cells derive from exocrine glands and neuroendocrine cells from endocrine glands; however, mixed acinar-neuroendocrine-ductal carcinoma ...
A. Takano +7 more
semanticscholar +1 more source
Surgical Case Reports, 2023 Background There are many reports of port site recurrence after laparoscopic surgery for various types of cancer. However, only two cases of port site recurrence after laparoscopic pancreatectomy have been reported to date.
Takashi Aida +7 more
doaj +1 more source
Pancreatic Acinar Cell Carcinoma in the Setting of a BRCA1 Germline Mutation
Annals of Internal Medicine: Clinical Cases, 2022 Pancreatic acinar cell carcinoma (PACC) is a rare neoplasm of the exocrine pancreas. PACC’s molecular and genetic features are poorly elucidated compared with pancreatic ductal cell carcinoma. Here, we present the patient case of a woman in her late 60s,
Leticia Campoverde +2 more
doaj +1 more source
Yes-associated protein (YAP) in pancreatic cancer: at the epicenter of a targetable signaling network associated with patient survival. [PDF]
, 2018 Pancreatic ductal adenocarcinoma (PDAC) is generally a fatal disease with no efficacious treatment modalities. Elucidation of signaling mechanisms that will lead to the identification of novel targets for therapy and chemoprevention is urgently needed ...
Eibl, Guido +2 more
core +2 more sources
Molecular Cancer, 2008 Background LIM-only 4 (LMO4), a member of the LIM-only (LMO) subfamily of LIM domain-containing transcription factors, was initially reported to have an oncogenic role in breast cancer.
Fujita Hayato +9 more
doaj +1 more source
Targeting claudin‐4 enhances chemosensitivity of pancreatic ductal carcinomas [PDF]
Cancer Medicine, 2019 AbstractClaudin (CLDN) family comprises of protein that form a tight junction, and is involved in regulating polarity and differentiation of cells. Here, we aimed to investigate the effects of inhibiting CLDN4 in pancreatic ductal carcinomas (PDC).
Takamitsu Sasaki +12 more
openaire +4 more sources
Recent Developments in the Treatment of Pancreatic Cancer
Acta Médica Portuguesa, 2023 Pancreatic duct adenocarcinoma is currently the sixth-leading cause of cancer death worldwide and the fourth in Europe, with a continuous increase in annual lethality in Portugal during the last two decades.
Jorge Paulino, Hélder Mansinho
doaj +1 more source
Para-aortic node involvement is not an independent predictor of survival after resection for pancreatic cancer [PDF]
, 2017 AIM To analyze the importance of para-aortic node status in a series of patients who underwent pancreaticoduodenectomy (PD) in a single Institution.
Beltrame, Valentina +7 more
core +1 more source
A Bioinformatics Study for Recognition of Hub Genes and Pathways in Pancreatic Ductal Adenocarcinoma [PDF]
arXiv, 2023 Background: The aim of this study is to use bioinformatics to discover the biomarkers associated with patients with Pancreatic Ductal Adenocarcinoma(PDAC). Material and Methods: GSE28735, GSE15471, and GSE62452 are gene microarray datasets drived from the GEO database, included 153 PDAC samples and 145 normal samples. By analyzing both Gene Ontology (
arxiv